FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Braeburn Pharmaceuticals BVBA SPRL 2. Date of Event Requiring Statement (Month/Day/Year) 11/25/2013 3. Issuer Name and Ticker or Trading Symbol TITAN PHARMACEUTICALS INC [TTNP] (Last) (First) (Middle) BRUGMANNLAAN 147 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) VORST, C9 1190 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 9,650,000 D (1) Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Braeburn Pharmaceuticals BVBA SPRL BRUGMANNLAAN 147 VORST, C9 1190	Â	  X	Â	Â
Apple Tree Consolidated BVBA SPRL BRUGMANNLAAN 147 VORST, C9 1190	Â	  X	Â	Â
Apple Tree Investments S.a.r.l 1 BOULEVARD DE LA FOIRE N4 L-1528	Â	  X	Â	Â
Apple Tree Partners IV, L.P. 47 HULFISH STREET, SUITE 441 PRINCETON, NJ 08542	Â	  X	Â	Â
ATP III GP, Ltd. 47 HULFISH STREET, SUITE 441 PRINCETON, NJ 08542	Â	  X	Â	Â
Harrison Seth Loring 47 HULFISH STREET, SUITE 441 PRINCETON, NJ 08542	Â	  X	Â	Â

Signatures

/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison, Manager of Braeburn Pharmaceuticals BVBA SPRL		12/04/2013
**Signature of Reporting Person		Date
/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison, Manager of Apple Tree Consolidated BVBA SPRL		12/04/2013
**Signature of Reporting Person		Date
/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison, Manager of Apple Tree Investments S.a.r.l		12/04/2013
**Signature of Reporting Person		Date
/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison, Manager of Braeburn Pharmaceuticals BVBA SPRL		12/04/2013
**Signature of Reporting Person		Date
/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison, Director of ATP III GP, Ltd, general partner of Apple Tree Partners IV, L.P.		12/04/2013
**Signature of Reporting Person		Date
/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison, Director of ATP III GP, Ltd.		12/04/2013
**Signature of Reporting Person		Date
/s/ Lauren Farrell, as attorney-in-fact for Seth L. Harrison		12/04/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Braeburn Pharmaceuticals BVBA SPRL ("Braeburn") is the record owner of the Shares. As the sole owner of Braeburn, Apple Tree Consolidated BVBA SPRL ("ATC") may be deemed to own beneficially the Shares. As the sole owner of ATC, Apple Tree Investments S.a.r.l ("ATI") may be deemed to own beneficially the Shares. As the sole owner of ATI, Apple Tree Partners IV, L.P. ("ATP IV") may be deemed to own beneficially the Shares. As the sole general partner of ATP IV, ATP III GP, Ltd. ("ATP GP") may be deemed to own beneficially the Shares. As the sole owner and director of ATP GP, Seth L. Harrison may be deemed to own beneficially the Shares. Each of the Reporting Persons, except Braeburn, disclaims beneficial ownership of the Shares except to the extent of their pecuniary interest therein, if any.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.